Síntesis, caracterización y ensayos cinéticos del nanocomposite RuO2/TiO2/MWCNT/Pt en la producción fotocatalítica de combustibles solares bajo iluminación UV y VIS

Se prepararon partículas de nanocomposites basados en TiO2 y nanotubos de carbono multicapa platinizados para la obtención de combustibles solares. Se evaluó la actividad fotocatalítica del material en la producción de hidrógeno, en procesos de degradación de ácido fórmico, y en la obtención de hidrocarburos a partir de la reducción de CO2 en agua. Los nanocomposites fueron sintetizados por medio de la técnica sol-gel. Se estudió el efecto de la proporción y el diámetro de los nanotubos de carbono en la actividad del material bajo iluminación ultravioleta y visible. Se estudió el efecto de la adición de RuO2 (0,5% wt.) en la actividad bajo iluminación visible. Los materiales fueron caracterizados por ATR, XRD, BET, HRTEM y SEM. Se obtuvieron sólidos macroporosos, con contenido de fase anatasa superior al 99% y tamaño cristalino comprendido entre 15 y 21 nm. Los resultados cinéticos mostraron una producción óptima de hidrógeno para el composite TiO2/(5wt.%)MWCNT/Pt(60-80 nm), con eficiencia cuántica y eficiencia energética de 1,27% y 0,27%, respectivamente. En el caso de radiación visible, la producción de hidrógeno fue nula para los composites TiO2/MWCNT/Pt, mientras que para el sistema RuO2/TiO2/MWCNT/Pt se observó que la adicción de MWCNT inhibía la actividad fotocatalítica del composite RuO2/TiO2 en la región del visible. Por otra parte, en los ensayos de reducción de CO2 no se detectó ningún producto de reacción.

Estudi de la interacció de tres complexos de Pt amb proteïnes i oligonucleòtids mitjançant ESI-MS

En aquest treball s’investiga la reactivitat de tres complexos de Pt, cisplatí, complex 1, [Pt(dmba)(aza-N1)(dmso)], complex 2, i [Pt(dmba)(N9-9AA)(PPh3)]+, complex 3; els quals presenten activitat antitumoral, amb diferents proteïnes i oligonucleòtids mitjançant espectrometria de masses (ESI-TOF MS). ). L’estudi del cisplatí, 1, droga molt coneguda i emprada avui en dia pel tractament de molts tipus de càncer, permet comparar la reactivitat dels nous complexos d’estudi, 2 i 3, els quals presenten un IC50 més baix que el cisplatí en algunes línies de cèl·lules tumorals.

Stratégies narratives et identité chez les romanciéres maghrébines

Les romancières maghrébines d'expression française essaient souvent de fairerésonner dans leurs oeuvres la voix interdite de toutes les femmes musulmanes, dereconstruire une identité mise en question. Cette entreprise est d'autant plus difficileque l'écriture reste encore une activité éminemment masculine (comme toutes cellesqui ont une projection publique) dans le monde arabe. Les difficultés qu'a tout écrivain francophone à faire publier ses textes au Maghreb sont ainsi redoublées s'il s'agit d'une écrivaine. Celles-ci, plus durement jugées par la critique (ou, sinon, suivant d'autres paramètres que ceux appliqués aux hommes écrivains, car on est plus enclin à rapporter le contenu des oeuvres à la biographie de leurs auteurs quand ceux-ci sont des femmes),doivent "faire ses preuves langagières", tel que l'exprime S. Rezzoug1. De cette façon,la femme qui écrit "renchérit souvent sur les principes de correction et de beau langage, et désireuse d'éviter la condamnation d'amoralisme, ou reproche plus grave, de narcissisme, use pour se dire d'une série de travestissements"...

Stratégies narratives et identité chez les romanciéres maghrébines

Les romancières maghrébines d'expression française essaient souvent de fairerésonner dans leurs oeuvres la voix interdite de toutes les femmes musulmanes, dereconstruire une identité mise en question. Cette entreprise est d'autant plus difficileque l'écriture reste encore une activité éminemment masculine (comme toutes cellesqui ont une projection publique) dans le monde arabe. Les difficultés qu'a tout écrivain francophone à faire publier ses textes au Maghreb sont ainsi redoublées s'il s'agit d'une écrivaine. Celles-ci, plus durement jugées par la critique (ou, sinon, suivant d'autres paramètres que ceux appliqués aux hommes écrivains, car on est plus enclin à rapporter le contenu des oeuvres à la biographie de leurs auteurs quand ceux-ci sont des femmes),doivent "faire ses preuves langagières", tel que l'exprime S. Rezzoug1. De cette façon,la femme qui écrit "renchérit souvent sur les principes de correction et de beau langage, et désireuse d'éviter la condamnation d'amoralisme, ou reproche plus grave, de narcissisme, use pour se dire d'une série de travestissements"...

Complexes of Pd(II) and Pt(II) with 9-aminoacridine: reactions with DNA and study of their antiproliferative activity

Four new metal complexes {M = Pd(II) or Pt(II)} containing the ligand 9-aminoacridine (9AA) were prepared. The compounds were characterized by FT-IR and 1H, 13C, and 195Pt NMR spectroscopies. Crystal structure of the palladium complex of formulae [Pd(9AA)(μ-Cl)]2 · 2DMF was determined by X-ray diffraction. Two 9-acridine molecules in the imine form bind symmetrically to the metal ions in a bidentate fashion through the imine nitrogen atom and the C(1) atom of the aminoacridine closing a new five-membered ring. By reaction with phosphine or pyridine, the Cl bridges broke and compounds with general formulae [Pd(9AA)Cl(L)] (where L = PPh3 or py) were formed. A mononuclear complex of platinum of formulae [Pt(9AA)Cl(DMSO)] was also obtained by direct reaction of 9-aminoacridine and the complex [PtCl2(DMSO)2]. The capacity of the compounds to modify the secondary and tertiary structures of DNA was evaluated by means of circular dichroism and electrophoretic mobility. Both palladium and platinum compounds proved active in the modification of both the secondary and tertiary DNA structures. AFM images showed noticeable modifications of the morphology of the plasmid pBR322 DNA by the compounds probably due to the intercalation of the complexes between base pairs of the DNA molecule. Finally, the palladium complex was tested for antiproliferative activity against three different human tumor cell lines. The results suggest that the palladium complex of formula [Pd(9AA)(μ-Cl)]2 has significant antiproliferative activity, although it is less active than cisplatin.

Complexes of Pd(II) and Pt(II) with 9-aminoacridine: reactions with DNA and study of their antiproliferative activity

Four new metal complexes {M = Pd(II) or Pt(II)} containing the ligand 9-aminoacridine (9AA) were prepared. The compounds were characterized by FT-IR and 1H, 13C, and 195Pt NMR spectroscopies. Crystal structure of the palladium complex of formulae [Pd(9AA)(μ-Cl)]2 · 2DMF was determined by X-ray diffraction. Two 9-acridine molecules in the imine form bind symmetrically to the metal ions in a bidentate fashion through the imine nitrogen atom and the C(1) atom of the aminoacridine closing a new five-membered ring. By reaction with phosphine or pyridine, the Cl bridges broke and compounds with general formulae [Pd(9AA)Cl(L)] (where L = PPh3 or py) were formed. A mononuclear complex of platinum of formulae [Pt(9AA)Cl(DMSO)] was also obtained by direct reaction of 9-aminoacridine and the complex [PtCl2(DMSO)2]. The capacity of the compounds to modify the secondary and tertiary structures of DNA was evaluated by means of circular dichroism and electrophoretic mobility. Both palladium and platinum compounds proved active in the modification of both the secondary and tertiary DNA structures. AFM images showed noticeable modifications of the morphology of the plasmid pBR322 DNA by the compounds probably due to the intercalation of the complexes between base pairs of the DNA molecule. Finally, the palladium complex was tested for antiproliferative activity against three different human tumor cell lines. The results suggest that the palladium complex of formula [Pd(9AA)(μ-Cl)]2 has significant antiproliferative activity, although it is less active than cisplatin.

Complexes of Pd(II) and Pt(II) with 9-aminoacridine: reactions with DNA and study of their antiproliferative activity

Four new metal complexes {M = Pd(II) or Pt(II)} containing the ligand 9-aminoacridine (9AA) were prepared. The compounds were characterized by FT-IR and 1H, 13C, and 195Pt NMR spectroscopies. Crystal structure of the palladium complex of formulae [Pd(9AA)(μ-Cl)]2 · 2DMF was determined by X-ray diffraction. Two 9-acridine molecules in the imine form bind symmetrically to the metal ions in a bidentate fashion through the imine nitrogen atom and the C(1) atom of the aminoacridine closing a new five-membered ring. By reaction with phosphine or pyridine, the Cl bridges broke and compounds with general formulae [Pd(9AA)Cl(L)] (where L = PPh3 or py) were formed. A mononuclear complex of platinum of formulae [Pt(9AA)Cl(DMSO)] was also obtained by direct reaction of 9-aminoacridine and the complex [PtCl2(DMSO)2]. The capacity of the compounds to modify the secondary and tertiary structures of DNA was evaluated by means of circular dichroism and electrophoretic mobility. Both palladium and platinum compounds proved active in the modification of both the secondary and tertiary DNA structures. AFM images showed noticeable modifications of the morphology of the plasmid pBR322 DNA by the compounds probably due to the intercalation of the complexes between base pairs of the DNA molecule. Finally, the palladium complex was tested for antiproliferative activity against three different human tumor cell lines. The results suggest that the palladium complex of formula [Pd(9AA)(μ-Cl)]2 has significant antiproliferative activity, although it is less active than cisplatin.

Unbreakable PT symmetry of solitons supported by inhomogeneous defocusing nonlinearity

Peer Reviewed